OrganaBio
PrivateMomentum
Top 10%
of companies Caplight tracks
Company Overview
OrganaBio is a biotechnology company that provides ethically sourced biological products, cell processing, and manufacturing services to support cell and gene therapy developers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Pharma Supply Chain, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OrganaBio Comparables
Compare OrganaBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CGT Global | 80% | |
| Discovery Life Sciences | 78% | |
| Theragent | 77% | |
OrganaBio Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 12, 43% of headcount.
- Jul 13, 2026
Open roles increased to 7, 2.2x the trailing average.
OrganaBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OrganaBio's valuation, stock price, and market status.